The Cutting Edge of Medical Technology Content, Community & Collaboration
GE Healthymagination Fund, a new equity fund for health care technology companies, made the investment as part of a potential $44.5 million Series D financing round undertaken by CardioDx...
CardioDX, founded in early 2005 and led by President and CEO David Levison, a year ago started marketing its Corus CAD test. That is shoebox-size kit that uses a two-teaspoon draw of blood to test for obstructive coronary disease...
... CardioDx’s lab runs the blood across 23 genes in its algorithm and reports back with a score — from zero to 40 — that translates into the likelihood of a patient having heart disease.
Tags:
© 2025 Created by CC-Conrad Clyburn-MedForeSight. Powered by